American Heart Journal
Volume 141, Issue 6 , Pages 889-892 , June 2001

Aortic counterpulsation in acute myocardial infarction: Physiologically important but does the patient benefit?

Received 18 January 2001 ,Accepted 16 February 2001.

References 

  1. Nanas JN, Moulopoulos SD. Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects. Cardiology. 1994;84:156–167
  2. Mueller H, Ayres SM, Conklin EF, et al.  The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest. 1971;50:1885–1900
  3. Kern MJ, Aguirre F, Bach R, et al.  Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation. 1993;87:500–511
  4. Kern MJ, Aguirre FV, Tatineni S, et al.  Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol. 1993;21:359–368
  5. O’Rourke MF, Norris RM, Campbell TJ, et al.  Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol. 1981;47:815–820
  6. Flaherty JT, Becker LC, Weiss JL, et al.  Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. J Am Coll Cardiol. 1985;6:434–446
  7. Ryan TJ, Anderson JL, Antman EM, et al.  1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol. 1996;28:1328–1428
  8. Menon V, Hochman JS, Stebbins A, et al.  Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J. 2000;21:1928–1936
  9. Hudson MP, Granger CB, Stebbins AL, et al.  Cardiogenic shock survival and use of intraaortic balloon counterpulsation: results from the GUSTO I and III trials. Circulation. 1999;(100Suppl):I370
  10. Sanborn TA, Sleeper LA, Bates E, et al.  Impact of thrombolysis, aortic counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2000;36:1123–1129
  11. Moulopoulos S, Stamatelopoulos S, Petrou P. Intraaortic balloon assistance in intractable cardiogenic shock. Eur Heart J. 1986;7:396–403
  12. Waksman R, Weiss AT, Gotsman MS, et al.  Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J. 1993;14:71–74
  13. Kovack PJ, Rasak MA, Bates ER, et al.  Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol. 1997;29:1454–1458
  14. Rogers WJ, Canto JG, Lambrew CT, et al.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000;36:2056–2063
  15. Ohman EM, Nannas J, Stomel RJ, et al.  Thrombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS): results of a prospective randomized trial. Circulation. 2000;102(18Suppl):II600
  16. Norell MS. Randomized trials in cardiogenic shock: what’s the problem? [editorial, comment]. Eur Heart J. 1999;20:987–988
  17. Goldberg RJ, Samad NA, Yarzebski J, et al.  Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162–1168
  18. Hochman JS, Sleeper LA, White HD, et al.  One year survival following early revascularization for acute myocardial infarction complicated by cardiogenic shock. JAMA. 2001;285:190–192
  19. Ohman EM, Topol EJ, Califf RM, et al.  An analysis of the cause of early mortality after administration of thrombolytic therapy. Coron Artery Dis. 1993;4:957–964
  20. Gu S, Ducas J, Patton JN, et al.  Coronary thrombolysis: comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase. Chest. 1992;101:1684–1690
  21. Gurbel PA, Anderson RD, MacCord CS, et al.  Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. Circulation. 1994;89:361–365
  22. Prewitt RM, Gu S, Schick U, et al.  Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol. 1994;23:794–798
  23. Anderson RD, Ohman EM, Holmes DR, et al.  Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study. J Am Coll Cardiol. 1997;30:708–715
  24. 31st Bethesda Conference. Emergency cardiac care (1999). J Am Coll Cardiol. 2000;35:825–880
  25. Ohman EM, Califf RM, George BS, et al.  The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J. 1991;121:895–901
  26. Stone GW, Marsalese D, Brodie BR, et al.  A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1997;29:1459–1467
  27. van’t Hof AW, Liem AL, de Boer MJ, et al.  A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J. 1999;20:659–665
  28. Stone GW, Marsalese D, Brodie B, et al.  The routine of intra aortic balloon after primary PTCA improves clinical outcomes in very high risk patients with acute myocardial infarction—results of the PAMI-2 trial [abstract]. Circulation. 1995;92:I139
  29. Ohman EM, George BS, White CJ, et al.  Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction: results of a randomized trial. Circulation. 1994;90:792–799
  30. Bengtson JR, Kaplan AJ, Pieper KS, et al.  Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992;20:1482–1489
  31. Brodie BR, Stuckey TD, Hansen C, et al.  Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol. 1999;84:18–23

☆ E. M. O. has served as ad hoc consultant and has received research grants from Datascope Corp and Genentech Corp.

☆☆ Reprint requests: E. Magnus Ohman, MD, Division of Cardiology, University of North Carolina at Chapel Hill, 324 Burnett-Womack Bldg, CB #7075, Chapel Hill, NC 27599. E-mail: Ohman001@mc.duke.edu

★ Am Heart J 2001;141:889-92.

PII: S0002-8703(01)35227-4

doi: 10.1067/mhj.2001.115296

American Heart Journal
Volume 141, Issue 6 , Pages 889-892 , June 2001

Article Tools